loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Certificates of Suitability (CEPs) for r0_cep_2023_167___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CURIA SPAIN S.A.U. Boecillo ES (1)

filter

01 Betamethasone sodium phosphate, Process II (1)

filter

01 U.S.A (1)

filter

01 Valid (1)

URL Supplier Web Content
R0-CEP 2023-167 - Rev 00
Valid
Chemical
2023-08-23
810
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2023-167 - Rev 00 of Curia Spain S.a.u. Boecillo Es

Looking for Certificates of Suitability (CEPs) for R0-CEP 2023-167 - Rev 00 of Curia Spain S.a.u. Boecillo Es 1

20

Curia Spain S.a.u. Boecillo Es, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.

One of their significant offerings is Betamethasone sodium phosphate, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2023-167 - Rev 00

This Chemical Type CEP, issued on August 23, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 810 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY